News and views
November 2012 Br J Cardiol 2012;19:162-4
Decision by consensus: more political correctness or a genuine improvement in care?
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column, he considers team working...
August 2012 Br J Cardiol 2012;19:107–10
New ESC Guidelines on heart failure and CVD prevention
The European Society of Cardiology (ESC) has published two new guidelines – ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, and European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)....
August 2012 Br J Cardiol 2012;19:107–10
HDL particles may be key to risk
With all the recent controversy about whether raising high-density lipoprotein (HDL) is actually a worthwhile strategy in the battle against heart disease, a new study has suggested that HDL particle concentration may be a better marker of risk. ...
August 2012 Br J Cardiol 2012;19:107–10
Stricter food policies could dramatically cut heart disease deaths
Tougher government policies on diet could prevent 30,000 cardiovascular deaths a year in the UK, according to a new study. Moves suggested include banning the use of industrial trans fats and further reductions in salt and saturated fats while encouraging greater consumption of fruit and vegetables....
August 2012 Br J Cardiol 2012;19:107–10
Lancet highlights damage of physical inactivity
Physical inactivity is responsible for 6% of the worldwide burden of coronary heart disease and 7% of type 2 diabetes cases, as well as 10% of breast and colon cancers, according to a series of papers on lack of exercise recently published in The Lancet (380:187–306)....
August 2012 Br J Cardiol 2012;19:107–10
Impressive results for polypill in new UK study
A new study of the polypill has shown large reductions in blood pressure and cholesterol levels, which if maintained long-term could translate into a substantial cut in heart attacks and strokes, the authors claim. ...
August 2012 Br J Cardiol 2012;19:107–10
New data reassures on bleeding risk with dabigatran in surgery patients
New data from the RE-LY trial show that dabigatran is associated with similar rates of bleeding and thrombotic complications to warfarin in patients who have to undergo invasive procedures and surgery. ...
August 2012 Br J Cardiol 2012;19:107–10
NICE – final guidance on rivaroxaban in DVT
The National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal determination (FAD) on the use of rivaroxaban, as an alternative to warfarin, for the treatment of deep vein thrombosis (DVT) and prevention of recurrent DVT. ...
August 2012 Br J Cardiol 2012;19:115–6
I guess that’s why they call it ‘The Blues’
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column, he considers surgical outfits....
